mesalamine has been researched along with Gastroduodenal Ulcer in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Excerpt | Relevance | Reference |
---|---|---|
"Gastroduodenal Crohn disease is a complex and difficult problem that is associated with serious complications and need for reoperation." | 1.30 | An audit of gastroduodenal Crohn disease: clinicopathologic features and management. ( Allan, RN; Keighley, MR; Yamamoto, T, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yamamoto, T | 1 |
Allan, RN | 1 |
Keighley, MR | 1 |
1 other study available for mesalamine and Gastroduodenal Ulcer
Article | Year |
---|---|
An audit of gastroduodenal Crohn disease: clinicopathologic features and management.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Child; Constriction, Pathologic; C | 1999 |